STOCKS TELEGRAPH

Tag: NAOV

  • Upcoming Presentation: NanoVibronix Inc. (NAOV) stock Rallies After Hours

    On January 07, NanoVibronix Inc. (NAOV) announced its presentation at the upcoming H.C. Wainwright BioConnect Virtual Conference. Consequently, the stock became bullish in the after-hours on Friday.

    During the regular session, NAOV stock traded in the red with a loss of 3.88% at its close of $0.99. Following the announcement, the stock gained 6.06% to reach $1.05 in the after hours.

    The noninvasive biological response-activating devices developer, NanoVibronix Inc. was founded in 2003. Currently, its 27.95 million outstanding shares trade at a market capitalization of $27.67 million.

    H.C. Wainwright BioConnect Conference

    As per Friday’s announcement, NAOV’s Chief Executive Officer will present at the conference. Furthermore, the H.C. Wainwright BioConnect Virtual Conference will take place from January 10 to January 13, 2022.

    Mr. Murphy will provide updates on the company’s business during the presentation.

    NAOV’s VA Distribution Network Expansion

    On January 06, the company announced the expansion of its VA distribution network. Delta Medical, LLC has been added to the distribution network in order to increase the sale of NAOV’s PainShield products to Veteran’s Administration hospitals and healthcare facilities.

    Further, it is owned by Justin A. Brooks, who has vast experience in medical devices and deep-rooted relationships within the VA system.

    Previously, the company had sighed a distribution agreement with Applied Medical Solutions, LLC. Applied Medical serves as the distributor of NAOV’s PainShield products to Veteran Administration facilities throughout the U.S. Added to that, now Delta Medical will be the sub-distributor of the products for expanding its access.

    PainShieldTM

    PainShield is NOAV’s ultrasound device that delivers a localized ultrasound effect for treating pain and inducing soft tissue healing at a targeted area. Moreover, PainShield can be used in any kind of setting, be it home or work or a clinical setting. It has been shown to effectively treat chronic and acute pains without any risk of abuse as is the case with most opioid-based pain treatments.

    NAOV’s Financial Results

    On November 16, the company announced its third-quarter financial results of 2021.

    According to the results, NOAV has revenue of $499,000 in the third quarter of 2021. Comparatively, the revenue was $150,000 in Q3 of 2020. This shows a humungous increase of 233% year over year.

    In addition, the company incurred a net loss of $6.7 million in the third quarter of 2021, against $922,000 in the year-ago period. Resultantly, the net loss per basic and diluted share was $0.26 and $0.10 in the third quarter of 2021 and 2020, respectively.

  • NAOV stock has plunged in the after-hours; Find out why

    NanoVibronix Inc. (NAOV) has plunged -7.07% at $0.79 in after-market trading hours on the last check Thursday. The NAOV stock lost -10.52% to complete the last trading session at $0.85. The price range of the NAOV stock was between $0.8324 and $0.931

    How NanoVibronix differentiates its medical devices

    NanoVibronix Inc. is a medical device company that specifically focuses on the manufacturing and sale of biological response-activating device that target would recovery, pain treatment, and biofilm prevention – all done noninvasively. The NAOV stock has a research and development team in Nesher, Israel that designs medical devices using its low-intensity surface acoustic wave which is proprietary and patented. NanoVibronix sells its product directly to clients and patients along with Federaly supply agreements with the United States. Similar distributor agreements are also made with India, Israel, Europe, and other international linkages.

    The SAW technology of the company is diversified due to its low-frequency ultrasound waves for medical applications which include bacterial colonization, biofilm disruption, and pain relief.  The leading products of the company include PainShield®, UroShield®, and WoundShieldTM.

    NAOV has secured another Federal Supply Schedule deal with VA

    On 2nd March 2021, NanoVibronix Inc. (NASDAQ: NAOV) announced that it entered into another Federal Supply Schedule agreement for its UroShield urology therapy device through a service-disabled veteran organization. This supply will be ordered through the Veterans Administration (VA) to make it easier to treat veterans with UroShield.

    The NAOV stock sells its medical devices directly but it also has a supply chain agreement with governmental contracts, particularly the Federal Supply Schedule in the USA. The FSS program is managed through a contract with the General Services Administration (GSA) which provides Federal agencies a more efficient and convenient process for procuring the commercial supplies in bulk for discounts. NAOV’s PainShield – a non-opioid pain therapy was also placed on FSS by the Veterans Administration on 1st September 2019.

    The veterans use Foley catheters which have a risk of catching Catheter-Associated Urinary Tract Infection (CAUTI) which is the leading cause of secondary hospital-acquired bloodstream infection. 40 million Americans undergo Urinary Catheterization, with 0.5 million CAUTI cases and 8000 deaths related to infection, every year.

    This is the market where UroShield is really differentiated and effective because it is attached to any indwelling urinary catheter as a disposable ultrasound device which reduces biofilm and prevents CAUTI. The ultrasound low intensity waves disrupt the docking mechanism of Bacteria and prevent bacterial colonization. UroShield is also effective against preventing hospitalization – a necessary action during the COVID-19 pandemic where hospitals focus on prioritizing hospital beds for COVID patients.

    NAOV is re-adjourning its Special Meeting of Stockholders again

    On 2nd March NAOV stock announced that its Special Meeting of Stockholders scheduled for 31st march, 2021 has been adjourned and rescheduled for 14th April 2021. This was done to allow more time for stockholders to vote.

    However on 14th April, the company announced again that the Special Meeting of Stockholders has been re-adjourned. It will now reconvene on 27th April 2021, at 10 am ET and virtually take place on the link here. NAOV will continue to solicit proxies from its stockholders and encourage them to vote before April 26, 20201 11:59 pm.

  • NanoVibronix Inc. (NAOV) stock rises in after-hour trading. Why is it so?

    NanoVibronix Inc. (NAOV) stock rises in after-hour trading. Why is it so?

    NanoVibronix Inc. (NAOV) stock rises by 7.84% in the after-hour trading session while there is no recent news available related to this gain in NAOV stock price. NanoVibronix is a medical device company specializing in the development of medical devices based on its innovative low intensity surface acoustic wave technology. This technology enables the development of low-frequency ultrasound waves for a range of medical applications, including the disruption of biofilms and bacteria invasion, as well as pain management.

    Recent Important Events

    On March 31, NAOV stock announced their Special Meeting of Stockholders, which was scheduled for March 31, 2021, that it has got postponed in order to give stockholders more time to vote. The meeting is set to take place again on April 14, 2021. NAOV would continue to receive proxies from its stockholders for the resolutions set out in the Company’s proxy statement throughout the time of postponement. Until properly repealed, proxies previously submitted in relation to the Special Meeting will be voted on at the reconvened meeting. All stockholders who have not yet voted are encouraged to do so before April 13, 2021.

    Also on March 2, 2021, NAOV revealed that through a service disabled veteran group, NAOV’s UroShield urology therapy device has been added to the Federal Supply Schedule, making it possible for Veterans being handled by the Veterans Administration to obtain and use the UroShield.

    The PainShield, NanoVibronix’s other patented product, was put on the Federal Supply Schedule on September 1, 2019, ensuring veterans’ access to non-opioid pain treatment. Veterans who have indwelling Foley catheters will now get UroShield which is a medication to prevent Catheter-Associated Urinary Tract Infections.

    Conclusion

    The postponement of Special Meeting of Stockholders could be the possible reason for this change in NAOV stock price since the meeting has yet to happen. Until the meeting takes place, we will probably witness the NAOV stock to vary quite a few time. The investors would also be looking forward to the final result of this meeting.

  • Pre-Market Cues: 30 Stocks Roaring for Change On December 14th

    Sonoma Pharmaceuticals Inc. (SNOA) stock plunged -7.53% to $8.1 in the pre-market trading after reporting partnership with Crown Laboratories to launch Microcyn® technology-based anti-itch over-the-counter products.

    Livent Corporation (NYSE: LTHM) shares are trading up 3.6% at $17.0 at the time of writing. Company’s 52-week ranged between $3.95 to $17.53. Analysts have a consensus price target of $16.50.

    Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) shares are trading down -5.45% at $2.95 at the time of writing after declaring offering of common stock. Company’s 52-week ranged between $1.03 to $5.31.

    NextDecade Corporation (NEXT) is down more than -7.25% at $3.2 in pre-market hours Monday December 14, 2020. The stock had jumped over 38.00% to $3.45 in the last trading session.

    FAT Brands Inc. (FAT) tumbled over -4.06% at $7.57 in pre-market trading today following the announcement from the company that it has entered into an agreement to combine with Fog Cutter Capital Group Inc. (FCCG), the Company’s controlling stockholder.

    Recro Pharma Inc. (REPH) stock soared 3.21% to $3.05 in the pre-market trading. The most recent rating by Stephens, on October 17, 2019, is an Overweight.

    Ampio Pharmaceuticals Inc. (AMPE) stock moved up 3.33 percent to $1.55 in the pre-market trading.

    ReTo Eco-Solutions Inc. (RETO), a Building Materials company, rose about 3.91% at $0.665 in pre-market trading Monday.

    Yiren Digital Ltd. (YRD) lost over -5.36% at $3.0 in pre-market trading Monday December 14, 2020. The firm recently announced that it has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug, Ampion™.

    Before the trading started on December 14, 2020, Sabre Corporation (SABR) is up 3.46% to reach $11.35. It has been trading in a 52-week range of $3.30 to $23.25.

    NantHealth Inc. (NH) is up more than 1.74% at $3.5 in pre-market hours Monday December 14, 2020. The company recently presented during a poster session at the San Antonio Breast Cancer Symposium (SABCS) new significant findings around the adoption of trastuzumab biosimilars in the treatment of HER2-positive breast cancer and the potential clinical and cost benefits of biosimilars. The stock had jumped over 22.42% to $3.44 in the last trading session.

    Torchlight Energy Resources Inc. (TRCH) stock soared 15.79% to $0.88 in the pre-market trading. The most recent rating by ROTH Capital, on March 13, 2020, is a Neutral.

    NIO Limited (NYSE: NIO) shares are trading down -6.38% at $39.3 at the time of writing following the announcement of pricing of offering of 68,000,000 American Depositary Shares. Company’s 52-week ranged between $2.11 to $57.20. Analysts have a consensus price target of $59.

    Lightbridge Corporation (LTBR) is down more than -2.4% at $3.66 in pre-market hours Monday December 14, 2020. The stock had jumped over 12.28% to $3.75 in the last trading session.

    Foresight Autonomous Holdings Ltd. (FRSX) stock moved up 2.31 percent to $1.77 in the pre-market trading after its affiliate, Rail Vision Ltd., has received an order from Knorr-Bremse Systeme für Schienenfahrzeuge GmbH, an affiliate of Knorr-Bremse AG (Frankfurt: KBX), for two samples of their light rail vehicle (LRV) system.

    Before the trading started on December 14, 2020, Hennessy Capital Acquisition Corp. IV (HCAC) is up 2.32% to reach $20.75. It has been trading in a 52-week range of $9.21 to $22.43.

    Inseego Corp. (INSG) stock soared 10.36% to $15.18 in the pre-market trading after reporting that the company is expanding its global footprint in Japan with the launch of its industry-leading 5G MiFi® M2000 mobile hotspot. The most recent rating by ROTH Capital, on August 06, 2020, is a Neutral.

    Mechel PAO (MTL) is down more than -3.66% at $1.84 in pre-market hours Monday December 14, 2020. The stock had jumped over 11.05% to $1.91 in the last trading session.

    JinkoSolar Holding Co. Ltd. (NYSE: JKS) shares are trading up 3.58% at $54.9 at the time of writing after declaring an update to 2020 annual general meeting agenda. Company’s 52-week ranged between $11.42 to $90.20. Analysts have a consensus price target of $55.

    Before the trading started on December 14, 2020, CureVac N.V. (CVAC) is up 6.7% to reach $125.99. It has been trading in a 52-week range of $36.15 to $151.80.

    Xeris Pharmaceuticals Inc. (XERS) grew over 2.84% at $4.7 in pre-market trading today after recent proclamation from company that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive Opinion for Ogluo™ (glucagon).

    Teligent Inc. (NASDAQ: TLGT) shares are trading up 85.54% at $1.17 at the time of writing. Company’s 52-week ranged between $0.46 to $6.46. Analysts have a consensus price target of $2.

    Marathon Patent Group Inc. (MARA) gained over 15.58% at $5.49 in pre-market trading Monday December 14, 2020. The firm recently announced a contract with Bitmain to purchase 10,000 Antminer S-19j Pro ASIC Miners.

    Sundial Growers Inc. (NASDAQ: SNDL) shares are trading up 4.64% at $0.53 at the time of writing after reporting that it has received approval to transfer the listing of its common shares to the Nasdaq Capital Market. Company’s 52-week ranged between $0.14 to $3.88.

    Neos Therapeutics Inc. (NEOS) tumbled over -5.61% at $0.6532 in pre-market trading today. The company and Aytu BioScience, Inc. (AYTU) recently declared that they have entered into a definitive merger agreement pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.

    Arbutus Biopharma Corporation (ABUS), a Biotechnology company, rose about 6.14% at $4.15 in pre-market trading Monday. The healthcare firm lately declared additional clinical data from an ongoing Phase 1a/1b clinical trial (AB-729-001) with AB-729, its proprietary GalNAc delivered RNAi compound.

    Greenwich LifeSciences Inc. (GLSI) lost over -16.07% at $47.0 in pre-market trading Monday December 14, 2020 following the publication of a second poster for the GP2 Phase III clinical trial design for recurring breast cancer at the San Antonio Breast Cancer Symposium (SABCS) in a virtual format.

    Veru Inc. (VERU) is up more than 19.12% at $7.57 in pre-market hours Monday December 14, 2020 following the company revealed positive Phase 2 clinical trial results for enobosarm, for the treatment of endocrine and chemotherapy resistant ER+/HER2- metastatic breast cancer. The stock had jumped over 6.45% to $6.36 in the last trading session.

    NanoVibronix Inc. (NAOV) stock plunged -6.36% to $1.03 in the pre-market trading after reporting that it has expanded and replaced its original distribution agreement with Ultra Pain Products, Inc..

    SELLAS Life Sciences Group Inc. (NASDAQ: SLS) shares are trading down -11.23% at $7.43 at the time of writing following the pricing of $16.2 million registered direct offering. Company’s 52-week ranged between $1.46 to $19.38.

  • Why NanoVibronix Inc [NAOV] Is the Stock to Watch after UroShield® Approval

    Why NanoVibronix Inc [NAOV] Is the Stock to Watch after UroShield® Approval

    NanoVibronix Inc [NASDAQ: NAOV] is on a roll this morning. The stock started gaining upside momentum pre-market when it gained by over 80%, and it’s not easing up. The stock’s upside momentum started after the company announced that the U.S FDA had given it the authorization to sell UroShield® in the U.S market. The FDA stated that UroShield® can apply the Intended Use Code 081.006: Enforcement Discretion Per Final Guidance. It can also use the FDA Product code QMK.

    The FDA authorization has opened the way for the company to start shipping UroShield® to the U.S during the COVID-19 pandemic. This effectively opens up the company’s market at a time when a product like UroShield® is needed in the market.  That’s because, by design, it helps prevent incidents of CAUTI in people suffering from ailments that need the long-term use of indwelling catheters.

    UroShield® achieves this because it is ultrasound-based, which means it is uniquely positioned to stop the buildup of bacteria on urinary catheters that are put inside. By its design, it helps cut on the possibility of catheter-related urinary tract infections, while also cutting on the possibility of CAUTI incidence in people that need long-term catheterization.

    Commenting on the breakthrough, CEO Brian Murphy stated that the FDA continued to carry out its mandate of protecting the public through various means that include shortening the time needed to review new medical devices that are beneficial to the public during the COVID-19 period.   He added that it is on this basis that the FDA approved UroShield® for its ability to lower urinary tract infections. The CEO also touched on the uniqueness of the product stating that at the moment, the company was not aware of any other devices that have the ability to avoid catheter-linked urinary tract infections with the same level of efficiency as UroShield®.

    From an investor perspective, the approval of UroShield® is a big deal for this stock’s value. That’s because it offers the company a foothold in one of the largest markets in the world.  Demand in the U.S is likely to be driven up by COVID-19 has led to an increase in people that need catheterization and the fact that UroShield® has no close competitors in the U.S. This points to higher revenues in the short-term, and a significant increase in the company’s intrinsic value.

    About NanoVibronix Inc

    NanoVibronix Inc makes and sells non-invasive devices that help prevent biofilm, and in pain therapy. It is headquartered in Elmsford, New York.

  • Stocks to Watch as Markets Rebound after Days of Selloffs

    Stocks to Watch as Markets Rebound after Days of Selloffs

    The markets are headed for a mixed start to the day. After several days of selloffs, things have stabilized with tech stocks leading the way. Investors are hopeful that a stimulus package if it comes through, would help support the economy after it took a hit due to the COVID-19 lockdowns. Nonetheless, sentiment remains weak as elections approach.

    Due to the huge difference in policies between President Trump and his main rival Joe Biden, investors are getting out of risky investments as they await the election and its outcome. This is likely to continue weighing in on the markets in the short term. There is also the fact that the COVID-19 pandemic continues to hang over the markets like a bad cloud.

    So far the numbers don’t seem to be slowing down, and in some places, they are accelerating. Essentially, this means a return to normalcy is still a far-fetched idea until a viable vaccine is found.  Despite the mixed market sentiment, there are stocks that are outperforming the markets this morning. Most of the early morning gainers are stocks that have released strong quarterly results that point to their underlying fundamental strength. Some of the big performers this morning are as follows:

    DavidsTEA Inc [NASDAQ: DTEA]

    DavidsTEA is a big gainer this morning and is up by over 30%. This comes after the company released strong Q2 financial results. The company announced that e-commerce sales increased by 189.9%, while wholesale sales rose to $23 million.

    The company reported that its Q2 results were a reflection of a successful strategic shift towards digital-first. Commenting on the results, CFO Frank Zitella stated that the company was impressed with the spillover of Q1 growth into Q2 that led to a 25% growth in sales. He added that customers were responding well to the company’s online experience and that the current strategy would see the company return to profitability.

    IKONICS Corporation [NASDAQ: IKNX]

    IKONICS Corporation is another big gainer this morning after it released Q2 results for 2020. While revenues declined due to the COVID-19 pandemic, the company took decisive steps to protect liquidity, and grow as normalcy returns. This seems to have excited the market more than the drastic drop in revenues.

    NanoVibronix Inc [NASDAQ: NAOV]

    NanoVibronix Inc is a top performer this morning and is up by over 70% pre-market. This follows the company’s announcement that it had got FDA approval to introduce NanoVibronix UroShield® in the U.S. UroShield® is an ultrasound product that prevents bacteria buildup on urinary catheters.